Among the top ten famous doctors in Beijing, look for Lin Lan to treat diabetes
Lin Lan, female, born on August 20, 1938, from Zhejiang, graduated in 1963 Department of Medical Care, Shanghai University of Traditional Chinese Medicine (six-year program). Currently, he is the chief researcher of the China Academy of Chinese Medical Sciences, director of the key endocrinology department of Guang'anmen Hospital, chief physician, and doctoral supervisor. He enjoys special government subsidies. Clinically, he is good at treating diabetes and its complications, thyroid diseases and difficult internal diseases.
At the same time, Lin Lan also serves as the academic leader of the "Key Specialties" of the National Health and Family Planning Commission, the "National Key Specialties of Traditional Chinese Medicine Endocrinology" and the "National Key Specialties of Endocrinology of Traditional Chinese Medicine" of the State Administration of Traditional Chinese Medicine. Consultation expert of the Health Commission and drug review expert of the State Drug Administration. He once served as the chairman of the Diabetes and Endocrinology Professional Committee of the Chinese Society of Integrated Traditional Chinese and Western Medicine and a director of the Chinese Medical Association.
Lin Lan’s professional research directions are, first, the study of diabetes and its complications, and second, the study of thyroid disease. She specializes in the treatment of diabetes and endocrine diseases complicated by vascular diseases of the heart, brain, kidneys, limbs, hyperthyroidism, and thyroid diseases using integrated traditional Chinese and Western medicine. The "Type Three Diabetes Syndrome Differentiation" created by him was first included in the "Guiding Principles for Clinical Research of New Drugs in Diabetes (Diabetes Disease)" and is still used today.
Based on the observation of more than 2,000 patients, Lin Lan divided diabetes into three types: yin deficiency and heat excess, qi and yin deficiency, and yin and yang deficiency. Correspondingly, it has been recognized by Western medicine. Lin Lan believes that the focus of treatment for different types of symptoms is different. For yin deficiency and heat excess, the focus is on dredging the collaterals, for qi and yin deficiency, the focus is on nourishing yin, and for yin and yang deficiency, the focus is on tonifying the kidneys and strengthening the foundation.
Different types of symptoms have different medications. Lin Lan took the principle of replenishing qi and nourishing yin and the research on the mechanism of hypoglycemic medicine of traditional Chinese medicine as the starting point, and successively developed "Jiangtang Jia Tablets" and "Jiangtang Tongmaining". New drugs such as "Qizhi Jiangtang Tablets", "Tangweikang Capsules" (Kelexin Capsules), "Tangxinping Capsules", and "Jiaokangning Capsules" have made great progress in the field of integrated traditional Chinese and Western medicine in the treatment of diabetes.
Lin Lan has successively served as the national “Ninth Five-Year Plan” and “Tenth Five-Year Plan” key research projects, National Natural Science Foundation projects, and National Administration of Traditional Chinese Medicine projects. Experimental Research", "Clinical and Experimental Research on Jiangtang Tongmaining in the Treatment of Diabetic Vascular Complications", "Research on the Treatment of Hyperthyroidism by Jiaokangtongmaining" and other scientific research topics.
The "Type Three Syndrome Differentiation of Diabetes" created by Lin Lan was first included in the "Guiding Principles for Clinical Research of New Drugs in Diabetes (Diabetes)" by the Pharmaceutical Administration of the People's Republic of China and the Ministry of Health, and has been used ever since. So far; at the same time, she was the first in China to advocate "replenishing qi and nourishing yin as the basic rule for preventing and treating diabetes" and developed the first traditional Chinese medicine hypoglycemic preparation in China.
Lin Lan was also the first in China to conduct dismantling research on traditional Chinese medicine compounds, exploring the hypoglycemic mechanism of traditional Chinese medicine from the perspectives of cell morphology and molecular biology. He proposed that "replenishing qi and nourishing yin, activating blood circulation and removing blood stasis are the main methods to prevent and treat diabetic vascular disease". He conducted a series of research on diabetes and its complications, invented and created a variety of traditional Chinese medicine preparations, and obtained 4 new drug certificates and 1 national patent.